R&D News | pharmaphorum

News

Will Gottlieb follow up on Trump's promise of a bonfire of regulations?

FDA reviewers back Pfizer/BioNTech COVID-19 vaccine ahead of...

Reviewers from the FDA have given their blessing to the Pfizer/BioNTech COVID-19 vaccine ahead of a key meeting tomorrow – but the regulator noted that there are still uncertainties about w

News

Sinovac raises $515m to boost production of potential COVID-...

China’s Sinovac has raised $515 million to increase its distribution and production capacity as clinical development of its potential coronavirus vaccine nears conclusion.

News

engineering and genetic editing through the Crispr technique. DNA chain breaking down. 3D rendering

ASH: CRISPR, Vertex' CTX001 hits the mark in red cell disord...

A gene-editing drug developed by CRISPR Therapeutics and Vertex Pharma has achieved “remarkable” improvements in patients with beta thalassaemia and sickle cell disease in an early-stage tr

News

Parasitic biting insect on background of epidermis detail. Disgusting carrier of encephalitis, Lyme disease or babesiosis infections. Tick-borne diseases

Valneva accelerates Lyme disease vaccine R&D project with Pf...

Valneva has said it plans to accelerate research into its Lyme disease vaccine candidate VLA15, bringing forward a trial including children into the first quarter of 2021.

News

"Tokyo, Japan - May 11, 2012: Pfizer building on May 11, 2012 in Tokyo. Pfizer is one of largest pharmaceutical companies worldwide with tremendous revenue $67.4 bn USD for 2011. It exists since 1849."

Pfizer cut vaccine production targets because of raw materia...

Pfizer slashed its production targets for its COVID-19 vaccine because of a lack of raw materials for its supply chain, according to press reports.

News

Janssen adds Hemera's AMD gene therapy to pipeline

Johnson & Johnson’s pharma unit Janssen has bought rights to an investigational gene therapy for a severe form age-related macular degeneration from specialist biotech Hemera Bioscience

FDA reviewers back Pfizer/BioNTech COVID-19 vaccine ahead of...

Sinovac raises $515m to boost production of potential COVID-...

ASH: CRISPR, Vertex' CTX001 hits the mark in red cell disord...

Valneva accelerates Lyme disease vaccine R&D project with Pf...

Pfizer cut vaccine production targets because of raw materia...

Janssen adds Hemera's AMD gene therapy to pipeline

After rival fails, Cytokinetics could broaden Myqorzo label

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks